Glaxo secures EU approval for Aids treatment
Glaxo Wellcome stayed one step ahead of its competitors in the HIV market when it won preliminary European Union approval for Trizivir, the first medicine to combine three Aids treatment in one
Glaxo Wellcome stayed one step ahead of its competitors in the HIV market when it won preliminary European Union approval for Trizivir, the first medicine to combine three Aids treatment in one